KYNB · Insider Trading
Kyntra Bio, Inc. Common Stock
Every open-market purchase and sale reported by KYNB officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Andrew E. Singer | Director | A | +14,000 deriv. | — |
| 2026-09-09 | David DeLucia | Chief Financial Officer | F | −22 | −$188 |
| 2026-09-09 | Thane Wettig | CEO | F | −209 | −$1.79K |
| 2026-06-17 | Michael Kauffman | Director | A | +7,000 deriv. | — |
| 2026-06-17 | Jeffrey L Edwards | Director | A | +7,000 deriv. | — |
| 2026-06-17 | Maykin Ho | Director | A | +7,000 deriv. | — |
| 2026-06-17 | James A Schoeneck | Director | A | +7,000 deriv. | — |
| 2026-06-09 | Thane Wettig | CEO | F | −198 | −$1.33K |
| 2026-06-09 | David DeLucia | Chief Financial Officer | F | −52 | −$349 |
| 2026-05-19 | Thane Wettig | CEO | Buy | +2,800 | +$19.85K |
| 2026-05-18 | Thane Wettig | CEO | Buy | −2,800 | −$19.85K |
| 2026-03-10 | David DeLucia | Chief Financial Officer | F | −60 | −$410 |
| 2026-03-10 | Thane Wettig | CEO | F | −277 | −$1.89K |
| 2026-02-05 | Thane Wettig | CEO | A | +60,000 deriv. | — |
| 2026-02-05 | David DeLucia | Chief Financial Officer | A | +26,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Thane Wettig | CEO | 26,836 | $120.76K |
| David DeLucia | Chief Financial Officer | 4,355 | $19.60K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KYNB quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.